Entering text into the input field will update the search result below

Ultragenyx Pharmaceutical beats by $0.10, beats on revenue

Feb. 20, 2018 4:20 PM ETUltragenyx Pharmaceutical Inc. (RARE) StockBy: Akanksha Bakshi, SA News Editor
  • Ultragenyx Pharmaceutical (NASDAQ:RARE): Q4 EPS of -$1.89 beats by $0.10.
  • Revenue of $2.41M beats by $2.23M.
  • Shares -0.12%.
  • Press Release

Recommended For You

More Trending News

About RARE Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
RARE--
Ultragenyx Pharmaceutical Inc.